In the European Union, antimicrobial resistance (AMR) is estimated to be responsible for 33,000 deaths a year, and economic losses of over €1.5 billion to the economy, for example, in health care costs and productivity losses.

Hospitals are considered hotspots for the development and spread of drug-resistant bacteria, with approximately 75% of drug-resistant bacteria associated with healthcare. In a consortium with six procuring authorities, the Catalan Agency for Health Information, Assessment, and Quality launched pre-commercial procurement procedures to research and develop innovative solutions that contribute to unmet societal needs, like AMR.

The consortium supports and finances the development of a smart ICT solution that will improve the quality of care processes in hospitals, reduce both the health care and governmental costs and the operational impact, and improves the appropriateness and effectiveness of antimicrobial medicine usage.

Read the complete case study.


About SHiPP

The Sustainable Health in Procurement Project (SHiPP) was a four-year program developed by the United Nations Development Programme (UNDP) in collaboration with Health Care Without Harm and funded by the Swedish International Development and Cooperation Agency (SIDA), that aimed to reduce the harm to people and the environment caused by the manufacture, use, and disposal of medical products and by the implementation of health programs.

With an expansive and diverse network of over 1,700 members in more than 80 countries, GGHH was a key vehicle to engage the health sector around the globe on sustainable procurement through the Sustainable Health in Procurement Project (SHiPP). 

Learn more